Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

915 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Possible Exposures Among Mpox Patients Without Reported Male-to-Male Sexual Contact - Six U.S. Jurisdictions, November 1-December 14, 2022.
Sharpe JD, Charniga K, Byrd KM, Stefanos R, Lewis L, Watson J, Feldpausch A, Pavlick J, Hand J, Sokol T, Ortega E, Pathela P, Hennessy RR, Dulcey M, McHugh L, Pietrowski M, Perella D, Shah S, Maroufi A, Taylor M, Cope A, Belay ED, Ellington S, McCollum AM, Zilversmit Pao L, Guagliardo SAJ, Dawson P. Sharpe JD, et al. Among authors: ortega e. MMWR Morb Mortal Wkly Rep. 2023 Sep 1;72(35):944-948. doi: 10.15585/mmwr.mm7235a2. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37651279 Free article.
Epidemiologic and Clinical Characteristics of Monkeypox Cases - United States, May 17-July 22, 2022.
Philpott D, Hughes CM, Alroy KA, Kerins JL, Pavlick J, Asbel L, Crawley A, Newman AP, Spencer H, Feldpausch A, Cogswell K, Davis KR, Chen J, Henderson T, Murphy K, Barnes M, Hopkins B, Fill MA, Mangla AT, Perella D, Barnes A, Hughes S, Griffith J, Berns AL, Milroy L, Blake H, Sievers MM, Marzan-Rodriguez M, Tori M, Black SR, Kopping E, Ruberto I, Maxted A, Sharma A, Tarter K, Jones SA, White B, Chatelain R, Russo M, Gillani S, Bornstein E, White SL, Johnson SA, Ortega E, Saathoff-Huber L, Syed A, Wills A, Anderson BJ, Oster AM, Christie A, McQuiston J, McCollum AM, Rao AK, Negrón ME; CDC Multinational Monkeypox Response Team. Philpott D, et al. Among authors: ortega e. MMWR Morb Mortal Wkly Rep. 2022 Aug 12;71(32):1018-1022. doi: 10.15585/mmwr.mm7132e3. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35951487 Free PMC article.
Notes from the Field: Mpox Cluster Caused by Tecovirimat-Resistant Monkeypox Virus - Five States, October 2023-February 2024.
Gigante CM, Takakuwa J, McGrath D, Kling C, Smith TG, Peng M, Wilkins K, Garrigues JM, Holly T, Barbian H, Kittner A, Haydel D, Ortega E, Richardson G, Hand J, Hacker JK, Espinosa A, Haw M, Kath C, Bielby M, Short K, Johnson K, De La Cruz N, Davidson W, Hughes C, Green NM, Baird N, Rao AK, Hutson CL. Gigante CM, et al. Among authors: ortega e. MMWR Morb Mortal Wkly Rep. 2024 Oct 10;73(40):903-905. doi: 10.15585/mmwr.mm7340a3. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39388389 Free PMC article.
Impact of Dietary Niacin on Metabolic Dysfunction-Associated Steatotic Liver Disease in Mediterranean Subjects: A Population-Based Study.
Antentas M, Rojo-López MI, Vendrell P, Granado-Casas M, Genua I, Fernandez-Camins B, Rossell J, Niño-Narvión J, Moreira E, Castelblanco E, Ortega E, Vlacho B, Alonso N, Mauricio D, Julve J. Antentas M, et al. Among authors: ortega e. Nutrients. 2024 Nov 30;16(23):4178. doi: 10.3390/nu16234178. Nutrients. 2024. PMID: 39683571 Free PMC article.
Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study.
Martín-Escolano R, Virseda-Berdices A, Berenguer J, González-García J, Brochado-Kith O, Fernández-Rodríguez A, Díez C, Hontañon V; Marathon Study Group; Resino S, Jiménez-Sousa MÁ. Martín-Escolano R, et al. Front Pharmacol. 2024 Oct 28;15:1341612. doi: 10.3389/fphar.2024.1341612. eCollection 2024. Front Pharmacol. 2024. PMID: 39530457 Free PMC article.
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Harter P, Marth C, Mouret-Reynier MA, Cropet C, Lorusso D, Guerra-Alía EM, Matsumoto T, Vergote I, Colombo N, Mäenpää J, Lebreton C, de Gregorio N, Mosconi AM, Rubio-Pérez MJ, Bourgeois H, Fasching PA, Cecere SC, Hardy-Bessard AC, Denschlag D, de Percin S, Hanker L, Favier L, Bauerschlag D, Desauw C, Hillemanns P, Largillier R, Sehouli J, Grenier J, Pujade-Lauraine E, Ray-Coquard I; PAOLA-1/ENGOT-ov25 investigators. Harter P, et al. Ann Oncol. 2024 Nov 9:S0923-7534(24)04907-X. doi: 10.1016/j.annonc.2024.10.828. Online ahead of print. Ann Oncol. 2024. PMID: 39528049 Free article.
915 results